Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Japan to halt company applications for workplace vaccinations

06/23/2021 | 08:58am EDT

The Japanese government said Wednesday it is temporarily halting company applications for COVID-19 vaccinations at workplaces due to concerns it will be unable to distribute doses quickly enough.

Applications will be closed off to companies after 5 p.m. Friday, with no timeline set for when they will resume, Taro Kono, the minister in charge of the inoculation effort, told a press conference.

Kono said the government has hit its ceiling for how many doses of Moderna Inc.'s vaccine it can deliver to companies daily and most of the 50 million doses it expects to receive shipments of by September have already been allocated.

Applications for large-scale vaccination sites set up by prefectures, which also use the Moderna vaccine, will stop immediately, he said.

The move, which comes as Prime Minister Yoshihide Suga is seeking to finish inoculating everyone eligible among Japan's population of 125 million by November, does not affect hospitals and clinics administering Pfizer Inc.'s vaccine.

Vaccinations began Monday at major companies including Central Japan Railway Co. and SoftBank Group Corp. as well as on university campuses, ramping up a rollout that until then had largely been limited to health care workers and people aged 65 or older.

The government "will take appropriate steps to ensure vaccinations continue to go smoothly," Suga said in a meeting Wednesday with members of his Cabinet including Kono and health minister Norihisa Tamura.

==Kyodo

© Kyodo News International, Inc., source Newswire

All news about MODERNA, INC.
09:28aPFIZER : FDA asks Pfizer, Moderna to widen trials for COVID-19 vaccines in child..
AQ
06:12aManufacturing Woes Plague Shipment of Moderna COVID-19 Jab to South Korea
MT
02:52aSINOVAC BIOTECH : Antibodies from Sinovac's COVID-19 shot fade after about 6 mon..
RE
02:22aDassault Systemes lifts 2021 outlook on surging software sales
RE
02:21aSupply issues to delay Moderna COVID-19 vaccine shipments, S.Korea says
RE
01:37aS.korea says moderna reported that other countries receiving supply from lonz..
RE
01:28aModerna reported s.korea of problems in its vaccine manufacturing process -s...
RE
01:20aModerna pushes back july vaccine shipment schedule for s.korea to aug -s.kore..
RE
01:20aMODERNA : pushes back July vaccine shipment for S.Korea to Aug
RE
12:38aS.Korea begins COVID-19 vaccination for chip, electronics workers
RE
More news
Financials (USD)
Sales 2021 19 117 M - -
Net income 2021 10 725 M - -
Net cash 2021 11 948 M - -
P/E ratio 2021 13,3x
Yield 2021 -
Capitalization 135 B 135 B -
EV / Sales 2021 6,43x
EV / Sales 2022 7,18x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 335,87 $
Average target price 179,20 $
Spread / Average Target -46,6%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.221.50%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.38.02%47 396
CELLTRION, INC.-26.46%31 265
SEAGEN INC.-18.34%25 955
CUREVAC N.V.-33.14%21 497